Targets › OTC
6 programs from 6 companies in 6 trials: 3 Phase 1, 2 Phase 3, 1 Phase 2; Metabolic and endocrine; next expected readout Jun 2027.
Catalyzes the second step of the urea cycle, the condensation of carbamoyl phosphate with L-ornithine to form L-citrulline. The urea cycle ensures the detoxification of ammonia by converting it to urea for excretion. (UniProt, P00480)
Open in Phaseline: the race on OTC, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical | DTX301 (avalotcagene ontaparvovec) AAV8-mediated gene transfer encoding functional OTC | OTC | Phase 3 | OTC Deficiency | Sep 2027 |
| iECURE | ECUR-506 Gene editing therapy delivering OTC gene | OTC | Phase 3 | Ornithine Transcarbamylase Deficiency | Dec 2027 |
| Arcturus Therapeutics | ARCT-810 Ornithine Transcarbamylase (OTC) mRNA in lipid nanoparticle formulation | OTC | Phase 2 | OTC Deficiency | – |
| University College, London | AAVLK03hOTC Recombinant AAV-delivered ornithine transcarbamylase gene therapy | OTC | Phase 1 | Ornithine Transcarbamylase Deficiency | Jun 2027 |
| CAMP4 Therapeutics | CMP-CPS-001 Antisense oligonucleotide targeting OTC (ornithine transcarbamylase) | OTC | Phase 1 | Healthy Volunteers | Dec 2027 |
| Rebecca Ahrens-Nicklas | LNP.UCD.ABE adenine base editor (ABE) delivered by lipid nanoparticle (LNP) for urea cycle disorder ge | CPS1, OTC, ASS1, ASL, ARG1 | Phase 1 | Urea Cycle Disorders | Sep 2028 |
Ornithine Transcarbamylase Deficiency (2) OTC Deficiency (2) Healthy Volunteers (1) Urea Cycle Disorders (1)
other (2), protein or peptide (2), small molecule (1), mixed (1)
University College, London (1) CAMP4 Therapeutics (1) Rebecca Ahrens-Nicklas (1) Ultragenyx Pharmaceutical (1) Arcturus Therapeutics (1) iECURE (1)
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.